The UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function.*1,2 Patients also experienced significant improvement in quality of life. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea.
*No instances of new, sustained erectile or ejaculatory dysfunction
1. McVary, J Sex Med 2014
2. Roehrborn, J Urology 2013 LIFT Study
Company’s Keywords:
<1
<
<